{
    "title": "Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia",
    "pmid": "30336686",
    "pmcid": "PMC6714829",
    "study_parameters": [
        {
            "Study Parameters ID": 1451226980,
            "Variant Annotation ID": 1451226960,
            "Study Type": "cohort",
            "Study Cases": 542.0,
            "Study Controls": null,
            "Characteristics": null,
            "Characteristics Type": "Unknown",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.016",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1451226960"
        },
        {
            "Study Parameters ID": 1451227040,
            "Variant Annotation ID": 1451227020,
            "Study Type": "cohort",
            "Study Cases": 542.0,
            "Study Controls": null,
            "Characteristics": null,
            "Characteristics Type": "Unknown",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.52",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1451227020"
        }
    ],
    "var_drug_ann": [
        {
            "Variant Annotation ID": 1451226960,
            "Variant/Haplotypes": "rs4149056",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 30336686,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "Patients carrying 521TT genotype had greater TC and LDL-C reduction in response to simvastatin after 4 weeks of treatment.",
            "Sentence": "Genotype TT is associated with increased response to simvastatin in people with Hypercholesterolemia as compared to genotypes CC + CT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "response to",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Hypercholesterolemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC + CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "30336686",
            "Variant Annotation ID_norm": "1451226960"
        },
        {
            "Variant Annotation ID": 1451227020,
            "Variant/Haplotypes": "rs2306283",
            "Gene": "SLCO1B1",
            "Drug(s)": "simvastatin",
            "PMID": 30336686,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Patients carrying 388G allele alone is not significantly associated with greater TC and LDL-C reduction in response to simvastatin after 4 weeks of treatment. no significant associations were found between the 521T>C and 388A>G polymorphisms and the lipid-lowering effects of simvastatin treatment after 8 weeks.",
            "Sentence": "Genotypes AG + GG are not associated with increased response to simvastatin in people with Hypercholesterolemia as compared to genotype AA.",
            "Alleles": "AG + GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "response to",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Hypercholesterolemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA",
            "Comparison Metabolizer types": null,
            "PMID_norm": "30336686",
            "Variant Annotation ID_norm": "1451227020"
        }
    ],
    "var_pheno_ann": [],
    "var_fa_ann": []
}